Clinical Trial

C-Path Announces Gender Equitable Medicines for Parkinson’s Disease (GEM-PD) Initiative

C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden impact. TUCSON, Ariz., Nov.…

2 months ago

Ethics Board Approval Granted for Lexaria’s 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

DehydraTECH clinical test article manufacturing has been completed KELOWNA, BC / ACCESSWIRE / November 13, 2024 / Lexaria Bioscience Corp.…

2 months ago

Jaguar Health Reports Third Quarter 2024 Financial Results

The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately…

2 months ago

Water Tower Research Highlights IRB Approval for the Ainos VELDONA Clinical Sjogren’s Trial Alongside 3Q24 Earnings and Developments

Taiwan regulatory approval for the trial expected in Q1 2025Remains committed to a capital-efficient business strategySAN DIEGO, CA / ACCESSWIRE…

2 months ago

CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types

CMTA strengthens its role as the leading force in comprehensive CMT research, forging a new strategic alliance with the Inherited…

2 months ago

Aviv Clinics Unveils Compelling Results on Treatment for Veterans Suffering from Post-Traumatic Stress Disorder

Novel Hyperbaric Oxygen Therapy Shows Promise in Treating Combat-Related PTSD in Veterans, lessening symptoms with lifechanging outcomesORLANDO, Fla., Nov. 13,…

2 months ago

myTomorrows Appoints Vanessa Lemarié as Chief Operating Officer

Previously COO at leading health technology company Ada Health, Lemarié is an award-winning strategist whose expertise will further myTomorrows' mission…

2 months ago

Defence Announces Radiopharmaceutical Expert Svetlana Selivanova Joins Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or…

2 months ago

ANGLE presents two posters at EACR

PARSORTIX-BASED ASSAYS SHOWCASED AT THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH LIQUID BIOPSIES CONFERENCETwo posters highlight the importance of epitope-independent CTC…

2 months ago